Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial

DSpace Repository

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial

Author: Broeckelmann, Paul J.; Buehnen, Ina; Meissner, Julia; Trautmann-Grill, Karolin; Herhaus, Peter; Halbsguth, Teresa V.; Schaub, Valdete; Kerkhoff, Andrea; Mathas, Stephan; Bormann, Matthias; Dickhut, Andreas; Kaul, Helen; Fuchs, Michael; Kobe, Carsten; Baues, Christian; Borchmann, Peter; Engert, Andreas; von Tresckow, Bastian
Tübinger Autor(en):
Schaub, Valdete
Published in: Journal of Clinical Oncology (2023), Bd. 41, H. 6, S. 1193
Verlagsangabe: Lippincott Williams & Wilkins
Language: English
Full text: http://dx.doi.org/10.1200/JCO.22.02355
ISSN: 0732-183X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)